José Baselga, Renowned Oncologist, Dies at 61
José Baselga, Renowned Oncologist, Dies at 61
The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.
José Baselga, Renowned Oncologist, Dies at 61
José Baselga, Renowned Oncologist, Dies at 61

The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.

The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.

breast cancer
Homing Technology Delivers Therapy to Cancerous Bone
Homing Technology Delivers Therapy to Cancerous Bone
Roni Dengler, PhD | Jul 19, 2021
A clever approach to modifying already existing cancer therapies may be a game changer for treating metastatic breast cancer.
Cancer Vaccines: Raising a T Cell Army
Cancer Vaccines: Raising a T Cell Army
The Scientist Creative Services Team | Apr 1, 2021
Vaccines against various forms of cancer prime the immune system to attack.
Gloria Echeverria Investigates an Insidious Form of Breast Cancer
Gloria Echeverria Investigates an Insidious Form of Breast Cancer
Max Kozlov | Dec 1, 2020
The newly minted Baylor College of Medicine faculty member is working to crack the mystery of triple negative breast cancer.
Heart Attack Elevates Risk of Breast Cancer Recurrence: Study
Heart Attack Elevates Risk of Breast Cancer Recurrence: Study
Amanda Heidt | Jul 13, 2020
Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.
Blood Test Detects Cancer Early, But Has Some Holdups
Blood Test Detects Cancer Early, But Has Some Holdups
Ashley Yeager | Apr 29, 2020
The liquid biopsy, which detects cell-free tumor DNA, spotted undiagnosed cancers in some women, but had a greater number of false positives and false negatives.
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Robert Fortner | Apr 12, 2020
Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.
Image of the Day: Synthetic Scaffolds
Image of the Day: Synthetic Scaffolds
Amy Schleunes | Feb 27, 2020
Three-dimensional polymer matrices offer researchers a new representation of the extracellular matrix that can be used to study the growth of cancer cells.
Janette Sherman, Public Health Activist, Dies
Janette Sherman, Public Health Activist, Dies
Emily Makowski | Nov 18, 2019
The physician, toxicologist, and expert witness drew attention to health issues caused by radiation and toxic chemicals.
Aggressive Cancers Feed Off the Brain’s Nerves
Aggressive Cancers Feed Off the Brain’s Nerves
Emily Makowski | Sep 20, 2019
Three studies show that tumor cells can behave like neurons.
Image of the Day: Actin Assembly
Image of the Day: Actin Assembly
Emily Makowski | Sep 17, 2019
Microtubules need actin to disassemble focal adhesions, allowing for cell movement.
Laskers Go to Immunologists, Developers of Breast Cancer Therapy
Laskers Go to Immunologists, Developers of Breast Cancer Therapy
Jef Akst | Sep 10, 2019
The 2019 Lasker medical and research awards celebrate advances in scientists’ understanding of T and B cells, Herceptin antibodies for treating breast cancer, and vaccine coverage around the globe.
Laura Bowers Works to Sever the Link Between Obesity and Cancer
Laura Bowers Works to Sever the Link Between Obesity and Cancer
Shawna Williams | Jul 15, 2019
The Purdue University nutrition researcher delves into the details of how fat tissue affects tumors.
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
Catherine Offord | Jul 9, 2019
Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?
Henry Lynch, Leader in Cancer Genetics, Dies
Henry Lynch, Leader in Cancer Genetics, Dies
Chia-Yi Hou | Jun 7, 2019
The Creighton University researcher discovered the genetic basis of hereditary breast-ovarian cancer syndrome.
Q&A: Epigenetic Therapies for Breast Cancer
Q&A: Epigenetic Therapies for Breast Cancer
Katarina Zimmer | Apr 4, 2019
Breast cancer researcher and oncologist Nancy Davidson discusses what we’ve learned from the first wave of epigenetic trials for breast cancer, and what challenges lie ahead before such therapies reach the clinic.
Sophia Lunt Traces the Effect of Metabolism on Cancer Metastasis
Sophia Lunt Traces the Effect of Metabolism on Cancer Metastasis
Ashley Yeager | Apr 1, 2019
The Michigan State University researcher’s lab experiences shaped her interest in the role of glucose in cancer’s spread.
Image of the Day: Metastatic Moment
Image of the Day: Metastatic Moment
Carolyn Wilke | Feb 27, 2019
A human breast cancer cell divides as it moves through surrounding blood vessel cells in vitro.
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Ashley P. Taylor | Oct 22, 2018
Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.
Image of the Day: Switch Gears
Image of the Day: Switch Gears
Sukanya Charuchandra | Sep 10, 2018
A gene responsible for the free-moving, primitive nature of fetal cells is expressed in some breast cancer cells in mice and humans.